{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T17:05:52Z","timestamp":1776704752844,"version":"3.51.2"},"reference-count":28,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,8,7]],"date-time":"2012-08-07T00:00:00Z","timestamp":1344297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hemodialysis International"],"published-print":{"date-parts":[[2013,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Regional citrate anticoagulation (<jats:styled-content style=\"fixed-case\">RCA<\/jats:styled-content>) is a valid anticoagulation method in continuous renal replacement therapies (<jats:styled-content style=\"fixed-case\">CRRT<\/jats:styled-content>) and different combination of citrate and <jats:styled-content style=\"fixed-case\">CRRT<\/jats:styled-content> solutions can affect acid\u2010base balance. Regardless of the anticoagulation protocol, hypophosphatemia occurs frequently in <jats:styled-content style=\"fixed-case\">CRRT<\/jats:styled-content>. In this case report, we evaluated safety and effects on acid\u2010base balance of a new <jats:styled-content style=\"fixed-case\">RCA\u2010 continuous veno\u2010venous hemofiltration (CVVH<\/jats:styled-content>) protocol using an 18\u2009<jats:styled-content style=\"fixed-case\">mmol\/L<\/jats:styled-content> citrate solution combined with a phosphate\u2010containing replacement fluid. In our center, <jats:styled-content style=\"fixed-case\">RCA\u2010CVVH<\/jats:styled-content> is routinely performed with a 12\u2009<jats:styled-content style=\"fixed-case\">mmol\/L<\/jats:styled-content> citrate solution and a postdilution replacement fluid with bicarbonate (protocol <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>). In case of persistent acidosis, not related to citrate accumulation, bicarbonate infusion is scheduled. In order to optimize buffers balance, a new protocol has been designed using recently introduced solutions: 18\u2009<jats:styled-content style=\"fixed-case\">mmol\/L<\/jats:styled-content> citrate solution, phosphate\u2010containing postdilution replacement fluid with bicarbonate (protocol <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>). In a cardiac surgery patient with acute kidney injury, acid\u2010base status and electrolytes have been evaluated comparing protocol <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content> (five circuits, 301\u2009hours) vs. protocol <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content> (two circuits, 97\u2009hours): <jats:styled-content style=\"fixed-case\">pH<\/jats:styled-content>\u20097.39\u2009\u00b1\u20090.03 vs. 7.44\u2009\u00b1\u20090.03 (P\u2009&lt;\u20090.0001), bicarbonate 22.3\u2009\u00b1\u20091.8 vs. 22.6\u2009\u00b1\u20091.4\u2009<jats:styled-content style=\"fixed-case\">mmol\/L<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">NS<\/jats:styled-content>), Base excess \u22122.8\u2009\u00b1\u20092.1 vs. \u22121.6\u2009\u00b1\u20091.2 (P\u2009=\u20090.007), phosphate 0.85\u2009\u00b1\u20090.2 vs. 1.3\u2009\u00b1\u20090.5\u2009<jats:styled-content style=\"fixed-case\">mmol\/L<\/jats:styled-content> (P\u2009=\u20090.027). Protocol <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content> required bicarbonate and sodium phosphate infusion (8.9\u2009\u00b1\u20092.8\u2009mmol\/h and 5\u2009g\/day, respectively) while protocol <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content> allowed to stop both supplementations. In comparison to protocol <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>, protocol <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content> allowed to adequately control acid\u2010base status without additional bicarbonate infusion and in absence of alkalosis, despite the use of a standard bicarbonate concentration replacement solution. Furthermore, the combination of a phosphate\u2010containing replacement fluid appeared effective to prevent hypophosphatemia.<\/jats:p>","DOI":"10.1111\/j.1542-4758.2012.00730.x","type":"journal-article","created":{"date-parts":[[2012,8,8]],"date-time":"2012-08-08T03:45:10Z","timestamp":1344397510000},"page":"313-320","source":"Crossref","is-referenced-by-count":17,"title":["Regional citrate anticoagulation in <scp>CVVH<\/scp>: A new protocol combining citrate solution with a phosphate\u2010containing replacement fluid"],"prefix":"10.1111","volume":"17","author":[{"given":"Santo","family":"Morabito","sequence":"first","affiliation":[{"name":"Department of Nephrology and Urology Hemodialysis Unit Umberto I Policlinico di Roma \u201cSapienza\u201d University  Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Pistolesi","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Urology Hemodialysis Unit Umberto I Policlinico di Roma \u201cSapienza\u201d University  Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Tritapepe","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Cardiac Surgery ICU Umberto I Policlinico di Roma \u201cSapienza\u201d University  Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Zeppilli","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Urology Hemodialysis Unit Umberto I Policlinico di Roma \u201cSapienza\u201d University  Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Polistena","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Urology Hemodialysis Unit Umberto I Policlinico di Roma \u201cSapienza\u201d University  Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Fiaccadori","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Nephrology and Health Sciences University of Parma Medical School  Parma Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Pierucci","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Urology Hemodialysis Unit Umberto I Policlinico di Roma \u201cSapienza\u201d University  Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,8,7]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-007-0754-4"},{"key":"e_1_2_6_3_1","first-page":"13","article-title":"Continuous renal replacement therapies (CRRT) will remain the most widely adopted dialysis modality in the critically ill","volume":"26","author":"Morabito S","year":"2009","journal-title":"G Ital Nefrol"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2010.100"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002480-199410000-00005"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001340000691"},{"key":"e_1_2_6_7_1","first-page":"566","article-title":"Continuous renal replacement therapies: Anticoagulation in the critically ill at high risk of bleeding","volume":"16","author":"Morabito S","year":"2003","journal-title":"J Nephrol"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndtplus\/sfp136"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc9358"},{"key":"e_1_2_6_10_1","first-page":"14","article-title":"Regional citrate anticoagulation: Towards a first\u2010choice treatment","volume":"29","author":"Morabito S","year":"2012","journal-title":"G Ital Nefrol"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-011-2438-3"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr106"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2010.00790.x"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.00809.x"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-004-2333-2"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802639"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0902413"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.570"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr075"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.2010.02338.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0656"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(81)90270-X"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp017"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc11403"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq575"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.2011.01001.x"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00040505"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2044.1998.00463.x"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc11363"}],"container-title":["Hemodialysis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1542-4758.2012.00730.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1542-4758.2012.00730.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1542-4758.2012.00730.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/j.1542-4758.2012.00730.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1542-4758.2012.00730.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T08:48:20Z","timestamp":1694249300000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1542-4758.2012.00730.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,7]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["10.1111\/j.1542-4758.2012.00730.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1542-4758.2012.00730.x","archive":["Portico"],"relation":{},"ISSN":["1492-7535","1542-4758"],"issn-type":[{"value":"1492-7535","type":"print"},{"value":"1542-4758","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,7]]}}}